Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01966471
Brief Title: A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer

First Submitted : October 17, 2013
First Submitted that Met QC Criteria : October 17, 2013
First Posted : October 21, 2013 (Estimate)

Results First Submitted : November 17, 2020
Results First Submitted that Met QC Criteria : December 18, 2020
Results First Posted : January 12, 2021

Last Update Submitted that Met QC Criteria : September 28, 2021
Last Update Posted : September 30, 2021